High Mobility Group Box 1 and Interleukin 6 at intensive care unit admission as biomarkers in critically ill COVID-19 patients

Exuberant inflammation manifesting as a “cytokine storm” has been suggested as a central feature in the pathogenesis of severe coronavirus disease 2019 (COVID-19). This study investigated two prognostic biomarkers, the high mobility group box 1 (HMGB1) and interleukin-6 (IL-6), in patients with seve...

Full description

Bibliographic Details
Main Authors: Sivakorn, C, Dechsanga, J, Jamjumrus, L, Boonnak, K, Schultz, MJ, Dorndorp, AM, Phumratanaprapin, W, Ratanarat, R, Naorungroj, T, Wattanawinitchai, P, Siripoon, T, Duangdee, C, Techarang, T
Format: Journal article
Language:English
Published: American Society of Tropical Medicine and Hygiene 2021

Similar Items